Clincosm LogoSign in Get a demo

Recurrent Ovarian Carcinoma

Showing 51 - 75 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Bronx, New York

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bronx, New York
  • +2 more
Oct 18, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +17 more
  • Phoenix, Arizona
  • +162 more
Sep 28, 2021

Recurrent Ovarian Carcinoma Trial in Austria

Recruiting
  • Recurrent Ovarian Carcinoma
    • Graz, Austria
    • +8 more
    Sep 1, 2021

    Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,

    Completed
    Has Results
    • Ovarian Endometrioid Adenocarcinoma
    • +8 more
    • Jacksonville, Florida
    • +1 more
    Sep 28, 2020

    High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Primary Peritoneal High Grade Serous

    Withdrawn
    • High Grade Fallopian Tube Serous Adenocarcinoma
    • +5 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jul 22, 2020

    Chemo-induced Peripheral Neuropathy, Recurrent Ovarian Carcinoma, Ovarian Cancer Trial in Seoul (sodium selenite pentahydrate,

    Recruiting
    • Chemotherapy-induced Peripheral Neuropathy
    • +4 more
    • sodium selenite pentahydrate
    • +2 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jul 15, 2020

    Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Carcinoma Trial in Korea, Republic of, United States (Laboratory Biomarker

    Completed
    Has Results
    • Ovarian Clear Cell Adenocarcinoma
    • Recurrent Ovarian Carcinoma
    • Laboratory Biomarker Analysis
    • Sunitinib Malate
    • Birmingham, Alabama
    • +96 more
    Feb 6, 2020

    Cervical Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Bronx (Palliative Therapy, Palliative Therapy +

    Completed
    • Cervical Carcinoma
    • +9 more
    • Palliative Therapy
    • Palliative Therapy + idiographic
    • Bronx, New York
      Albert Einstein College of Medicine
    Sep 13, 2019

    Adnexal Mass, Borderline Ovarian Epithelial Tumor, Ovarian Clear Cell Tumor Trial in Bay City, Detroit (Dexamethasone,

    Completed
    • Adnexal Mass
    • +6 more
    • Bay City, Michigan
    • +1 more
    Aug 12, 2019

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

    Completed
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +19 more
    • Hartford, Connecticut
    • +13 more
    Aug 8, 2019

    Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

    Completed
    Has Results
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Mobile, Alabama
    • +141 more
    Jul 22, 2019

    Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

    Completed
    • Ovarian Clear Cell Cystadenocarcinoma
    • +7 more
    • Bevacizumab
    • +4 more
    • Aurora, Colorado
    • +12 more
    Jul 19, 2019

    Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

    Completed
    • Advanced Malignant Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Scottsdale, Arizona
    • +1 more
    Jun 5, 2019

    Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

    Completed
    • Ovarian Clear Cell Cystadenocarcinoma
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +6 more
    Mar 8, 2019

    Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

    Completed
    Has Results
    • Adult Hepatocellular Carcinoma
    • +44 more
    • Scottsdale, Arizona
    • +60 more
    Jan 24, 2019

    Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor Trial in

    Completed
    Has Results
    • Fallopian Tube Carcinoma
    • +7 more
    • Hamilton, Ontario, Canada
    • +3 more
    Jul 20, 2018

    Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in United States (Laboratory Biomarker

    Completed
    • Basal-Like Breast Carcinoma
    • +16 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Duarte, California
    • +6 more
    Jun 28, 2018

    Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in United States (Paclitaxel

    Completed
    Has Results
    • Fallopian Tube Carcinoma
    • +2 more
    • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
    • Aurora, Colorado
    • +19 more
    Dec 14, 2017

    Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in United States (Laboratory Biomarker

    Completed
    Has Results
    • Fallopian Tube Carcinoma
    • +2 more
    • Laboratory Biomarker Analysis
    • PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1
    • Birmingham, Alabama
    • +10 more
    Dec 13, 2017

    Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Bronx, New York (Laboratory Biomarker Analysis,

    Completed
    • Estrogen Receptor Negative
    • +9 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Bronx, New York
    • +5 more
    Dec 21, 2017

    Adult Solid Tumor, Peritoneal Carcinomatosis, Recurrent Fallopian Tube Carcinoma Trial in Baltimore, Toronto (other, radiation,

    Completed
    • Adult Solid Neoplasm
    • +4 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Baltimore, Maryland
    • +2 more
    Nov 20, 2017

    Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

    Completed
    Has Results
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Rilotumumab
    • Burbank, California
    • +27 more
    Aug 8, 2017

    Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (drug, procedure,

    Withdrawn
    • Fallopian Tube Carcinoma
    • +4 more
    • Philadelphia, Pennsylvania
      Gynecologic Oncology Group
    Jul 12, 2017

    Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (Paclitaxel Poliglumex)

    Completed
    • Primary Peritoneal Carcinoma
    • Recurrent Ovarian Carcinoma
    • Paclitaxel Poliglumex
    • Philadelphia, Pennsylvania
      Gynecologic Oncology Group
    Jul 12, 2017

    Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Phoenix (Cositecan, Pharmacological Study)

    Completed
    • Primary Peritoneal Carcinoma
    • Recurrent Ovarian Carcinoma
    • Phoenix, Arizona
      Gynecologic Oncology Group of Arizona
    Jul 12, 2017